TomoTherapy Users Highlight Hi·Art(R) Clinical Advantages at Investor Meeting

MADISON, Wis.--(BUSINESS WIRE)--TomoTherapy Incorporated (NASDAQ: TOMO), maker of the Hi·Art® treatment system for advanced radiation therapy, held an investor meeting on March 13, 2008, at its headquarters in Madison, Wis. The event, arranged by investment firm William Blair & Company, included presentations from TomoTherapy’s management team and two clinical experts in the field of radiation oncology: Patrick Kupelian, M.D., and Chet Ramsey, Ph.D.

MORE ON THIS TOPIC